Empirical and Rational Design of T Cell Receptor-Based Immunotherapies

por Jones, Heather F., Molvi, Zaki, Klatt, Martin G., Dao, Tao, Scheinberg, David A.
Publicado 2021

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

por Molvi, Zaki, Klatt, Martin G, Dao, Tao, Urraca, Jessica, Scheinberg, David A, O'Reilly, Richard J
Publicado 2023

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

por Molvi, Zaki, Klatt, Martin G., Dao, Tao, Urraca, Jessica, Scheinberg, David A., O’Reilly, Richard J.
Publicado 2023

Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy

por Charles, Angel, Bourne, Christopher M., Korontsvit, Tanya, Aretz, Zita E. H., Mun, Sung Soo, Dao, Tao, Klatt, Martin G., Scheinberg, David A.
Publicado 2021

Solving an MHC allele–specific bias in the reported immunopeptidome

por Klatt, Martin G., Mack, Kyeara N., Bai, Yang, Aretz, Zita E. H., Nathan, Levy I., Mun, Sung Soo, Dao, Tao, Scheinberg, David A.
Publicado 2020

A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A*02:01 complex

por Dao, Tao, Mun, Sungsoo, Korontsvit, Tatyana, Khan, Abdul G., Pohl, Mary Ann, White, Thomas, Klatt, Martin G., Andrew, David, Lorenz, Ivo C., Scheinberg, David A.
Publicado 2022

Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy

por Hasan, Aisha N., Doubrovina, Ekaterina, Sottile, Rosa, Prockop, Susan, Klatt, Martin G., Heller, Glenn, Selvakumar, Annamalai, Barnett, Lorna, Hsu, Katharine C., O’Reilly, Richard J.
Publicado 2022

Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment

por Bourne, Christopher M., Mun, Sung Soo, Dao, Tao, Aretz, Zita E. H., Molvi, Zaki, Gejman, Ron S., Daman, Andrew, Takata, Katsuyoshi, Steidl, Christian, Klatt, Martin G., Scheinberg, David A.
Publicado 2022

The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8(+) T cells

por Kurachi, Makoto, Barnitz, R. Anthony, Yosef, Nir, Odorizzi, Pamela M., Dilorio, Michael A., Lemieux, Madeleine E., Yates, Kathleen, Godec, Jernej, Klatt, Martin G., Regev, Aviv, Wherry, E. John, Haining, W. Nicholas
Publicado 2014

Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody

por Dao, Tao, Mun, Sung Soo, Scott, Andrew C., Jarvis, Casey A., Korontsvit, Tatyana, Yang, Zhiyuan, Liu, Lianxing, Klatt, Martin G., Guerreiro, Manuel, Selvakumar, Annamalai, Brea, Elliott J., Oh, Claire, Liu, Cheng, Scheinberg, David A.
Publicado 2019

A TCR mimic monoclonal antibody reactive with the “public” phospho-neoantigen pIRS2/HLA-A*02:01 complex

por Dao, Tao, Mun, Sung Soo, Molvi, Zaki, Korontsvit, Tatyana, Klatt, Martin G., Khan, Abdul G., Nyakatura, Elisabeth K., Pohl, Mary Ann, White, Thomas E., Balderes, Paul J., Lorenz, Ivo C., O’Reilly, Richard J., Scheinberg, David A.
Publicado 2022

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

por Chandran, Smita S., Ma, Jiaqi, Klatt, Martin G., Dündar, Friederike, Bandlamudi, Chaitanya, Razavi, Pedram, Wen, Hannah Y., Weigelt, Britta, Zumbo, Paul, Fu, Si Ning, Banks, Lauren B., Yi, Fei, Vercher, Enric, Etxeberria, Inaki, Bestman, Watchain D., Da Cruz Paula, Arnaud, Aricescu, Ilinca S., Drilon, Alexander, Betel, Doron, Scheinberg, David A., Baker, Brian M., Klebanoff, Christopher A.
Publicado 2022